Annual report
9989.TEDINET S100TP0D
Period2023-04-01 → 2024-03-31
Filed2024-06-24
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 156
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥751.8bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales |
| Revenue | ¥690.5bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales |
| Revenue | ¥648.7bn | 2021-04-01 → 2022-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥634.3bn | 2020-04-01 → 2021-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥617.8bn | 2019-04-01 → 2020-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥41.0bn | 2023-04-01 → 2024-03-31 | Cons. | Operating income |
| Operating income | ¥37.5bn | 2022-04-01 → 2023-03-31 | Cons. | Operating income |
| Ordinary income | ¥41.7bn | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥38.1bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥34.7bn | 2021-04-01 → 2022-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥38.2bn | 2020-04-01 → 2021-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥37.2bn | 2019-04-01 → 2020-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥41.3bn | 2023-04-01 → 2024-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥37.7bn | 2022-04-01 → 2023-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥29.1bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥25.7bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥23.9bn | 2021-04-01 → 2022-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥25.3bn | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥23.7bn | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥29.1bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss |
| Net income | ¥25.7bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss |
| Total assets | ¥420.2bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥360.7bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥325.8bn | at 2022-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥308.5bn | at 2021-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥284.3bn | at 2020-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥167.1bn | at 2024-03-31 | Cons. | Liabilities |
| Total liabilities | ¥124.3bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥253.1bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥236.3bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥220.6bn | at 2022-03-31d | Cons. | Net assets |
| Net assets / equity | ¥205.2bn | at 2021-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥186.8bn | at 2020-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥69.7bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥80.9bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥69.7bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥80.9bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥89.3bn | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥86.5bn | at 2021-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥80.7bn | at 2020-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥41.2bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥37.4bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥31.7bn | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥31.8bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥32.3bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥74.8bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥28.5bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥20.7bn | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥17.9bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥13.9bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥22.5bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥17.3bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥8.2bn | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥8.1bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥7.9bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥249.07 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥219.83 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥204.02 | 2021-04-01 → 2022-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥216.68 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥202.67 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥219.82 | 2022-04-01 → 2023-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥204.01 | 2021-04-01 → 2022-03-31d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥216.63 | 2020-04-01 → 2021-03-31d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥202.67 | 2019-04-01 → 2020-03-31d | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥2,164.06 | at 2024-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,020.97 | at 2023-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,886.4 | at 2022-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,754.32 | at 2021-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,597.57 | at 2020-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 60.2% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 65.5% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 67.7% | at 2022-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 66.5% | at 2021-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 65.7% | at 2020-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 11.9% | 2023-04-01 → 2024-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 11.3% | 2022-04-01 → 2023-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 11.2% | 2021-04-01 → 2022-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 12.9% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 13.2% | 2019-04-01 → 2020-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 6,662 | at 2024-03-31 | Cons. | Number of employees |
| Employees | 6,371 | at 2023-03-31 | Cons. | Number of employees |
| Employees | 6,015 | at 2022-03-31d | Cons. | Number of employees |
| Employees | 5,634 | at 2021-03-31d | Cons. | Number of employees |
| Employees | 5,241 | at 2020-03-31d | Cons. | Number of employees |
| Revenue | ¥463.5bn | 2023-04-01 → 2024-03-31 | Standalone | Net sales |
| Revenue | ¥433.1bn | 2022-04-01 → 2023-03-31 | Standalone | Net sales |
| Revenue | ¥415.9bn | 2021-04-01 → 2022-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥413.0bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥412.6bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥24.7bn | 2023-04-01 → 2024-03-31 | Standalone | Operating income |
| Operating income | ¥22.7bn | 2022-04-01 → 2023-03-31 | Standalone | Operating income |
| Ordinary income | ¥25.3bn | 2023-04-01 → 2024-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥23.2bn | 2022-04-01 → 2023-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥21.3bn | 2021-04-01 → 2022-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥24.6bn | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥26.6bn | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥25.0bn | 2023-04-01 → 2024-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥22.9bn | 2022-04-01 → 2023-03-31 | Standalone | Income before income taxes |
| Net income | ¥17.8bn | 2023-04-01 → 2024-03-31 | Standalone | Profit loss |
| Net income | ¥15.7bn | 2022-04-01 → 2023-03-31 | Standalone | Profit loss |
| Net income | ¥14.9bn | 2021-04-01 → 2022-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥18.7bn | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥16.8bn | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥298.2bn | at 2024-03-31 | Standalone | Assets |
| Total assets | ¥255.1bn | at 2023-03-31 | Standalone | Assets |
| Total assets | ¥244.1bn | at 2022-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥235.3bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥214.1bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥123.2bn | at 2024-03-31 | Standalone | Liabilities |
| Total liabilities | ¥85.5bn | at 2023-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥175.0bn | at 2024-03-31 | Standalone | Net assets |
| Net assets / equity | ¥169.6bn | at 2023-03-31 | Standalone | Net assets |
| Net assets / equity | ¥163.9bn | at 2022-03-31d | Standalone | Net assets |
| Net assets / equity | ¥157.3bn | at 2021-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥145.6bn | at 2020-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥40.5bn | at 2024-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥54.7bn | at 2023-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥151.95 | 2023-04-01 → 2024-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥134.69 | 2022-04-01 → 2023-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥127.09 | 2021-04-01 → 2022-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥160.15 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥143.42 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥134.68 | 2022-04-01 → 2023-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥127.09 | 2021-04-01 → 2022-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥160.12 | 2020-04-01 → 2021-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥143.42 | 2019-04-01 → 2020-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥114 | 2023-04-01 → 2024-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥100 | 2022-04-01 → 2023-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥71 | 2021-04-01 → 2022-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥70 | 2020-04-01 → 2021-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥68 | 2019-04-01 → 2020-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥1,496.02 | at 2024-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,450.09 | at 2023-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,401.22 | at 2022-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,344.86 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,244.88 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 58.7% | at 2024-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 66.5% | at 2023-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 67.1% | at 2022-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 66.8% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 68.0% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 10.3% | 2023-04-01 → 2024-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 9.4% | 2022-04-01 → 2023-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 9.3% | 2021-04-01 → 2022-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 12.4% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 11.9% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 119,331,184 | at 2024-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 119,331,184 | at 2023-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 119,331,184 | at 2022-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 119,331,184 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 119,331,184 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 4,090 | at 2024-03-31 | Standalone | Number of employees |
| Employees | 3,895 | at 2023-03-31 | Standalone | Number of employees |
| Employees | 3,795 | at 2022-03-31d | Standalone | Number of employees |
| Employees | 3,517 | at 2021-03-31d | Standalone | Number of employees |
| Employees | 3,112 | at 2020-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 51
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2024-03-31 | −¥53.5bn |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2024-03-31 | −¥53.5bn |
| Reconciling Itemsreconciling | segment assets | at 2024-03-31 | −¥27.4bn |
| Discount Storereportable segment | capex | 2023-04-01 → 2024-03-31 | ¥13.8bn |
| Discount Storereportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥5.4bn |
| Discount Storereportable segment | employees | at 2024-03-31 | 1692 pure |
| Discount Storereportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥313.8bn |
| Discount Storereportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥313.8bn |
| Discount Storereportable segment | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥11m |
| Discount Storereportable segment | segment assets | at 2024-03-31 | ¥137.4bn |
| Discount Storereportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥15.3bn |
| Drug Storereportable segment | capex | 2023-04-01 → 2024-03-31 | ¥22.4bn |
| Drug Storereportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥9.7bn |
| Drug Storereportable segment | employees | at 2024-03-31 | 4970 pure |
| Drug Storereportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥491.4bn |
| Drug Storereportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥437.9bn |
| Drug Storereportable segment | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥53.5bn |
| Drug Storereportable segment | segment assets | at 2024-03-31 | ¥310.2bn |
| Drug Storereportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥25.7bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2023-04-01 → 2024-03-31 | ¥36.2bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2023-04-01 → 2024-03-31 | ¥15.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2024-03-31 | ¥805.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2024-03-31 | ¥751.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥53.5bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2024-03-31 | ¥447.6bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2024-03-31 | ¥41.0bn |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2023-03-31 | −¥49.6bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2023-03-31 | −¥49.6bn |
| Reconciling Itemsreconciling | segment assets | at 2023-03-31 | −¥26.1bn |
| Discount Storereportable segment | capex | 2022-04-01 → 2023-03-31 | ¥11.1bn |
| Discount Storereportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥4.9bn |
| Discount Storereportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥288.5bn |
| Discount Storereportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥288.5bn |
| Discount Storereportable segment | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥11m |
| Discount Storereportable segment | segment assets | at 2023-03-31 | ¥120.7bn |
| Discount Storereportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥13.8bn |
| Drug Storereportable segment | capex | 2022-04-01 → 2023-03-31 | ¥27.3bn |
| Drug Storereportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥7.2bn |
| Drug Storereportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥451.5bn |
| Drug Storereportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥402.0bn |
| Drug Storereportable segment | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥49.6bn |
| Drug Storereportable segment | segment assets | at 2023-03-31 | ¥266.0bn |
| Drug Storereportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥23.7bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2022-04-01 → 2023-03-31 | ¥38.4bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2022-04-01 → 2023-03-31 | ¥12.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2023-03-31 | ¥740.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2023-03-31 | ¥690.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥49.6bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2023-03-31 | ¥386.7bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2023-03-31 | ¥37.5bn |
| Drug Storereportable segment | employees | at 2024-03-31 | 4090 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,619
| Item | Context | Value | Unit |
|---|---|---|---|
| Fiscal year cover page | FilingDateInstant | Original text (Japanese)第61期(自 2023年４月１日 至 2024年３月31日) | |
| Company name cover page | FilingDateInstant | Original text (Japanese)株式会社サンドラッグ | |
| Company name in english cover page | FilingDateInstant | SUNDRUG CO.,LTD. | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役社長 CEO 貞方 宏司 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)東京都府中市若松町一丁目38番地の１ | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)０４２(３６９)６２１１(代表) | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)執行役員 管理本部長 加藤 好伸 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)東京都府中市若松町一丁目38番地の１ | |
| Telephone number nearest place of contact cover page | FilingDateInstant | Original text (Japanese)０４２(３６９)６２１１(代表) | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)執行役員 管理本部長 加藤 好伸 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E03226 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 99890 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)株式会社サンドラッグ | |
| Filer name in english | FilingDateInstant | SUNDRUG CO.,LTD. | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第三号様式 | |
| Accounting standards | FilingDateInstant | Japan GAAP | |
| Whether consolidated financial statements are prepared | FilingDateInstant | true | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | cte | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | cte | |
| Current fiscal year start date | FilingDateInstant | 2023-04-01 | |
| Current period end date | FilingDateInstant | 2024-03-31 | |
| Type of current period | FilingDateInstant | FY | |
| Current fiscal year end date | FilingDateInstant | 2024-03-31 | |
| Previous fiscal year start date | FilingDateInstant | 2022-04-01 | |
| Comparative period end date | FilingDateInstant | 2023-03-31 | |
| Previous fiscal year end date | FilingDateInstant | 2023-03-31 | |
| Next fiscal year start date | FilingDateInstant | － | |
| End date of quarterly or semi annual period of next fiscal year | FilingDateInstant | － | |
| Amendment flag | FilingDateInstant | false | |
| Identification of document subject to amendment | FilingDateInstant | － | |
| Report amendment flag | FilingDateInstant | false | |
| Xbrl amendment flag | FilingDateInstant | false | |
| Business results of group (text) | FilingDateInstant | Text · Plus | |
| Business results of reporting company (text) | FilingDateInstant | Text · Plus | |
| Company history (text) | FilingDateInstant | Text · Plus | |
| Description of business (text) | FilingDateInstant | Text · Plus | |
| Overview of affiliated entities (text) | FilingDateInstant | Text · Plus | |
| Information about employees (text) | FilingDateInstant | Text · Plus | |
| Consolidated subsidiaries metrics of consolidated subsidiaries | CurrentYearInstant_Row1Member | Original text (Japanese)㈱星光堂薬局 | |
| Consolidated subsidiaries metrics of consolidated subsidiaries | CurrentYearInstant_Row2Member | Original text (Japanese)㈱サンドラッグプラス | |
| Consolidated subsidiaries metrics of consolidated subsidiaries | CurrentYearInstant_Row3Member | Original text (Japanese)㈱大屋 | |
| Consolidated subsidiaries metrics of consolidated subsidiaries | CurrentYearInstant_Row4Member | Original text (Japanese)㈱サンドラッグ・ドリームワークス | |
| Consolidated subsidiaries metrics of consolidated subsidiaries | CurrentYearInstant_Row5Member | Original text (Japanese)ダイレックス㈱ | |
| Business policy business environment issues to address etc (text) | FilingDateInstant | Text · Plus | |
| Disclosure of sustainability related financial information (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |